Search Clinical Trials
598,193 trials
ID
Status
Phase
Title
Sponsor
NCT07763639
A Study of SI-B036 in Patients With Locally Advanced or Metastatic Head and Neck Tumors and Other Solid TumorsBaili-Bio (Chengdu) Pharmaceutical Co., Ltd.Not Yet RecruitingPhase 1
NCT07763639Not Yet Recruiting
Phase 1
A Study of SI-B036 in Patients With Locally Advanced or Metastatic Head and Neck...Baili-Bio (Chengdu) Pharm...
NCT07763457
Japanese Strabismus Outcomes Assessment and Research Group StudyKyoto University, Graduate School of MedicineNot Yet Recruiting
NCT07763457Not Yet Recruiting
—
Japanese Strabismus Outcomes Assessment and Research Group StudyKyoto University, Graduat...
NCT07764094
Impact of Procedural Factors on Drug-Coated Balloon Outcomes in Coronary Artery DiseaseNanjing First Hospital, Nanjing Medical UniversityRecruiting
NCT07764094Recruiting
—
Impact of Procedural Factors on Drug-Coated Balloon Outcomes in Coronary Artery...Nanjing First Hospital, N...
NCT07763353
Effects of Slow-paced Breathing on Heart Rate Variability in Patients With Heart FailureChung Shan Medical UniversityNot Yet RecruitingNot Applicable
NCT07763353Not Yet Recruiting
Not Applicable
Effects of Slow-paced Breathing on Heart Rate Variability in Patients With Heart...Chung Shan Medical Univer...
NCT07762742
A Comparative Study of Percutaneous Pulsed Field Ablation Guided by Ultrasound Alone Versus Fluoroscopy in Patients With Atrial FibrillationChina National Center for Cardiovascular DiseasesNot Yet RecruitingNot Applicable
NCT07762742Not Yet Recruiting
Not Applicable
A Comparative Study of Percutaneous Pulsed Field Ablation Guided by Ultrasound A...China National Center for...
NCT07763496
Relacorilant and Nab-Paclitaxel in Recurrent or Metastatic Cervical CancerARCAGY/ GINECO GROUPNot Yet RecruitingPhase 2
NCT07763496Not Yet Recruiting
Phase 2
Relacorilant and Nab-Paclitaxel in Recurrent or Metastatic Cervical CancerARCAGY/ GINECO GROUP
NCT07764081
Progression, Management, and Clinical Outcomes of Coronary Artery AneurysmsNanjing First Hospital, Nanjing Medical UniversityRecruiting
NCT07764081Recruiting
—
Progression, Management, and Clinical Outcomes of Coronary Artery AneurysmsNanjing First Hospital, N...
NCT07763093
Vertically Coronally Advanced Flap Versus Coronally Advanced Flap for Miller Class I Gingival RecessionUniversity of Medicine and Pharmacy at Ho Chi Minh CityActive Not RecruitingNot Applicable
NCT07763093Active Not Recruiting
Not Applicable
Vertically Coronally Advanced Flap Versus Coronally Advanced Flap for Miller Cla...University of Medicine an...
NCT07762911
Evaluation of an MRI-based Prostate Cancer Screening Program (VISIONING): 5-Year Follow-up Round (VISIONING III)University Hospital, Basel, SwitzerlandRecruitingNot Applicable
NCT07762911Recruiting
Not Applicable
Evaluation of an MRI-based Prostate Cancer Screening Program (VISIONING): 5-Year...University Hospital, Base...
NCT07762781
Impact of a Mobile Exercise Application on Sleep, Pain, and Fitness in Healthy AdultsTokat Gaziosmanpasa UniversityCompletedNot Applicable
NCT07762781Completed
Not Applicable
Impact of a Mobile Exercise Application on Sleep, Pain, and Fitness in Healthy A...Tokat Gaziosmanpasa Unive...
NCT07762001
Phase 1 Single-blind Placebo-controlled Dose Escalation Safety Study of AD-NP1Arjun Deb, MDActive Not RecruitingPhase 1
NCT07762001Active Not Recruiting
Phase 1
Phase 1 Single-blind Placebo-controlled Dose Escalation Safety Study of AD-NP1Arjun Deb, MD
NCT07763548
A Novel Two-Step Dosing Induction Strategy (The Propofol Challenge Test) to Minimize Propofol Injection PainErasme University HospitalNot Yet RecruitingPhase 4
NCT07763548Not Yet Recruiting
Phase 4
A Novel Two-Step Dosing Induction Strategy (The Propofol Challenge Test) to Mini...Erasme University Hospita...
NCT07762534
Physician vs Artificial Intelligence Counseling Before Elective Cesarean Delivery: A Randomized Controlled TrialWolfson Medical CenterNot Yet RecruitingNot Applicable
NCT07762534Not Yet Recruiting
Not Applicable
Physician vs Artificial Intelligence Counseling Before Elective Cesarean Deliver...Wolfson Medical Center
NCT07764172
Sarcopenia in Acute Ischemic StrokeUniversity Clinical Hospital na V.V.Vinogradov (branch of RUDN university na Patrice Lumumba)Recruiting
NCT07762274
The RenAtt Method for Diagnosing and Treating Attention Problems After Stroke and Brain Injury, Further Validation of RehAtt® DiSTRO Assessment of Cognitive and Visual FunctionDepartment of clinical sciences at Danderyd hospitalCompleted
NCT07762274Completed
—
The RenAtt Method for Diagnosing and Treating Attention Problems After Stroke an...Department of clinical sc...
NCT07764328
This Study Aims to Evaluate Whether Milamend's Product Could Improve Hormone Balance in Women Who Suffer From Self-reported PCOS Symptoms.Mila Mend Inc.RecruitingNot Applicable
NCT07764328Recruiting
Not Applicable
This Study Aims to Evaluate Whether Milamend's Product Could Improve Hormone Bal...Mila Mend Inc.
NCT07762768
Effect of CSIR-Developed High-Protein, Low-Glycaemic Index Rice on Glycaemic Response in Individuals With PrediabetesCSIR National Institute for Interdisciplinary Science and Technology (NIIST), ThiruvananthapuramNot Yet RecruitingNot Applicable
NCT07762768Not Yet Recruiting
Not Applicable
Effect of CSIR-Developed High-Protein, Low-Glycaemic Index Rice on Glycaemic Res...CSIR National Institute f...
NCT07762547
Evaluating Antiplatelet and Physical Therapy for Slowing Progression in Mild Moyamoya Disease.Beijing Tiantan HospitalNot Yet RecruitingNot Applicable
NCT07762547Not Yet Recruiting
Not Applicable
Evaluating Antiplatelet and Physical Therapy for Slowing Progression in Mild Moy...Beijing Tiantan Hospital
NCT07763184
mNGS for IFD in Patients With Hematological MalignanciesNanfang Hospital, Southern Medical UniversityNot Yet Recruiting
NCT07763184Not Yet Recruiting
—
mNGS for IFD in Patients With Hematological MalignanciesNanfang Hospital, Souther...
Result Breakdown
Not yet recruiting11 (55%)
Recruiting5 (25%)
Active, not recruiting2 (10%)
Completed2 (10%)
not_applicable9 (45%)
Not Specified7 (35%)
Phase 12 (10%)
Phase 21 (5%)
Phase 41 (5%)